GetPortalImpactFactorByIdResp(projectId=1, id=8e2012314, cover=https://img.medsci.cn/20231103/1698992197170_1614372.jpg, fullname=Therapeutic Advances in Respiratory Disease, abbr=THER ADV RESPIR DIS, pyear=2007, frequence=Bimonthly, articleNumbers=386, citedSelf2015=0.7, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均2.33月, reviewFee=null, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=1753-4658, greenSci=https://www.greensci.net/search?kw=1753-4658, scijournal=https://www.scijournal.org/impact-factor-of-THER-ADV-RESPIR-DIS.shtml, medsciHotlightString=null, medsciHotlightRealtime=6.079, medsciHotlight=2.746, medsciHotlight5year=2.77917, citescore=4.3, hIndex=37, impactFactor=4.3, orgnization=SAGE Publications Ltd, orgnizationUrl=https://uk.sagepub.com/en-gb/asi/home?utm_source=wechat&utm_medium=SAGE_social&utm_campaign=WeChat_MedSci1103, country=United Kingdom, countryCn=英国, isOa=1, isOaString=是, sciScie=Clarivate Analytics: Science Citation Index Expanded (SCIE) Directory of Open Access Journals (DOAJ) ProQuest PubMed Central (PMC) PubMed: MEDLINE Scopus, bigclassCas=医学 3区, smallclassCas=医学 3 区, website=https://journals.sagepub.com/home/TAR?utm_source=wechat&utm_medium=SAGE_social&utm_campaign=WeChat_MedSci1103, websiteHits=4263, guideForAuthor=https://journals.sagepub.com/author-instructions/TAR?utm_source=wechat&utm_medium=SAGE_social&utm_campaign=WeChat_MedSci1103, guideForAuthorHits=133, submitWebsite=https://mc.manuscriptcentral.com/tar?utm_source=wechat&utm_medium=SAGE_social&utm_campaign=WeChat_MedSci1103, submitWebsiteHits=1960, content=<p>该刊是经过同行评审的开放获取期刊，出版呼吸系统疾病领域的前沿探索和创新研究。</p>, totalCites=1663, brief=THER ADV RESPIR DIS杂志医学行业，“<strong><a target="_blank" href="/sci/index.do?smallclass=呼吸系统" >呼吸系统</a></strong>”子行业的优秀级杂志, articleType=本刊接收类型不明, medsciHeat=<span style="color: #990000;">暗红</span>, medsciComment=THER ADV RESPIR DIS杂志级别还可以，但是相对来说，比较冷门，关注人数偏少，有些可能是国内不太熟悉，但该杂志在国际仍然有相当知晓度的。因为缺少中国人投稿，稿源可能未必丰富，发表有可能有很大的机会哦。, medsciExplanation=MedSci期刊指数是根据中国科研工作者（含医学临床，基础，生物，化学等学科）对SCI杂志的认知度，熟悉程度，以及投稿的量等众多指标综合评定而成。当然，具体的，您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=8e2012314'>投稿经验系统</a>”，进行综合判断，这更是大家的实战经验，值得分享和参考。<br> 注意，上述MedSci期刊指数采用MedSci专利技术，由计算机系统自动计算，并给出建议，存在不准确的可能，仅供您投稿选择杂志时参考。, tags=null, citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2016, citescore=2.61), GetImpactFactorCiteScoreListResponse(year=2017, citescore=3.31), GetImpactFactorCiteScoreListResponse(year=2018, citescore=2.93), GetImpactFactorCiteScoreListResponse(year=2019, citescore=5.4), GetImpactFactorCiteScoreListResponse(year=2020, citescore=4.3)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=3.382), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=3.52), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=3.339), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=6.721), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=6.079)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Pulmonary and Respiratory Medicine , rank=28/134), GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Pharmacology (medical) , rank=58/232)], totalJcrAreaList=[], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1753-4658[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE[ta], article_number=49, article_number_cn=12, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)